Cargando…
The Conundrum of ‘Long-COVID-19ʹ: A Narrative Review
COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. ‘Long-COVID-19ʹ is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called ‘post-acu...
Autores principales: | Garg, Mandeep, Maralakunte, Muniraju, Garg, Suruchi, Dhooria, Sahajal, Sehgal, Inderpaul, Bhalla, Ashu Seith, Vijayvergiya, Rajesh, Grover, Sandeep, Bhatia, Vikas, Jagia, Priya, Bhalla, Ashish, Suri, Vikas, Goyal, Manoj, Agarwal, Ritesh, Puri, Goverdhan Dutt, Sandhu, Manavjit Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214209/ https://www.ncbi.nlm.nih.gov/pubmed/34163217 http://dx.doi.org/10.2147/IJGM.S316708 |
Ejemplares similares
-
Role of MRI in the Evaluation of Pulmonary Sequel Following COVID-19 Acute Respiratory Distress Syndrome (ARDS)
por: Garg, Mandeep, et al.
Publicado: (2023) -
Computed tomography chest in COVID-19: When & why?
por: Garg, Mandeep, et al.
Publicado: (2021) -
Safety of an immunomodulator Mycobacterium w in COVID-19
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2020) -
Ultra-Low Dose CT Chest in Acute COVID-19 Pneumonia: A Pilot Study from India
por: Garg, Mandeep, et al.
Publicado: (2023) -
High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
por: Dhooria, Sahajal, et al.
Publicado: (2022)